Harvard, MIT, Berkeley are still fighting over genome editing patents. Now another ruling

Who says organic chemistry doesn't have its drama? The US Patent Office's appeal board on Monday sided with Harvard University and MIT by upholding a set of the group's patents covering CRISPR-Cas9 genome editing in plants and animals.…